Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
34.57
-0.01 (-0.03%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Sanara MedTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 109.81 | 103.12 | 86.67 | 64.99 | 45.84 | 24.14 | |
Revenue Growth | 12.96% | 18.97% | 33.36% | 41.77% | 89.87% | 54.90% |
Cost of Revenue | 7.65 | 7.52 | 8.14 | 7.85 | 6.36 | 2.31 |
Gross Profit | 102.16 | 95.6 | 78.53 | 57.14 | 39.48 | 21.83 |
Selling, General & Admin | 84.44 | 78.72 | 71.67 | 56.99 | 46.09 | 28.26 |
Research & Development | 4.98 | 5.07 | 2.83 | 4.13 | 3.07 | 0.36 |
Operating Expenses | 91.9 | 86.45 | 76.78 | 64.8 | 51.53 | 29.21 |
Operating Income | 10.26 | 9.15 | 1.75 | -7.67 | -12.05 | -7.38 |
Interest Expense | -7.26 | -6.76 | -3.13 | -0.48 | - | -0 |
Interest & Investment Income | 0.07 | 0 | 0.02 | - | - | - |
Earnings From Equity Investments | -1.51 | -0.95 | -0.09 | - | -0.38 | -0.62 |
EBT Excluding Unusual Items | 1.56 | 1.44 | -1.45 | -8.14 | -12.43 | -7.99 |
Merger & Restructuring Charges | - | - | - | - | -0.19 | - |
Gain (Loss) on Sale of Investments | - | - | - | 0.25 | -1.04 | - |
Gain (Loss) on Sale of Assets | -0 | 0.01 | - | - | - | - |
Asset Writedown | -1.84 | -1.84 | -0.51 | - | - | - |
Other Unusual Items | - | - | 0.01 | 3.45 | -0.28 | - |
Pretax Income | -0.29 | -0.39 | -1.94 | -4.44 | -13.94 | -7.99 |
Income Tax Expense | - | - | - | - | -5.84 | - |
Earnings From Continuing Operations | -0.29 | -0.39 | -1.94 | -4.44 | -8.09 | -7.99 |
Earnings From Discontinued Operations | -31.73 | -37.17 | -7.73 | - | - | - |
Net Income to Company | -32.02 | -37.57 | -9.67 | -4.44 | -8.09 | -7.99 |
Minority Interest in Earnings | 0 | 0.01 | 0 | 0.14 | 0.15 | 0.07 |
Net Income | -32.01 | -37.56 | -9.66 | -4.3 | -7.94 | -7.92 |
Net Income to Common | -32.01 | -37.56 | -9.66 | -4.3 | -7.94 | -7.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 9 | 8 | 8 | 8 | 7 |
Shares Outstanding (Diluted) | 9 | 9 | 8 | 8 | 8 | 7 |
Shares Change | 1.58% | 1.64% | 2.48% | 4.71% | 7.70% | 28.02% |
EPS (Basic) | -3.68 | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
EPS (Diluted) | -3.69 | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4.5 | 2.16 | -0.23 | -3.51 | -5.7 | -4.99 |
Free Cash Flow Per Share | 0.52 | 0.25 | -0.03 | -0.42 | -0.72 | -0.68 |
Gross Margin | 93.03% | 92.71% | 90.61% | 87.92% | 86.13% | 90.43% |
Operating Margin | 9.34% | 8.87% | 2.02% | -11.79% | -26.27% | -30.55% |
Profit Margin | -29.15% | -36.43% | -11.15% | -6.62% | -17.32% | -32.81% |
Free Cash Flow Margin | 4.10% | 2.10% | -0.27% | -5.40% | -12.44% | -20.65% |
EBITDA | 12.75 | 11.81 | 4.03 | -3.99 | -9.67 | -6.78 |
EBITDA Margin | 11.61% | 11.45% | 4.65% | -6.14% | -21.10% | -28.08% |
D&A For EBITDA | 2.49 | 2.66 | 2.28 | 3.68 | 2.37 | 0.6 |
EBIT | 10.26 | 9.15 | 1.75 | -7.67 | -12.05 | -7.38 |
EBIT Margin | 9.34% | 8.87% | 2.02% | -11.79% | -26.27% | -30.55% |